NGL Fine-Chem informs about outcome of conference call

09 Feb 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that the Company participated in the Investors Conference Call on Wednesday, 9th February, 2022 on unaudited financial results for the quarter and nine months ended December 31, 2021. No unpublished price sensitive information was shared / discussed in the meeting. Audio of the conference call has been uploaded at the Company's website: www.nglfinechem.com/investors/Earnings Call & Investor Meeting.

The above information is a part of company’s filings submitted to BSE.


NGL Fine-Chem Share Price

1343.30 29.75 (2.26%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×